Original Article
Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:654-661
.
(10 October 2022)
This study investigates 68Ga-DOTA-PET imaging for monitoring disease state in NETs and demonstrates significant variability in SUV in both normal tissues as well as in primary and metastatic lesions. The data support the need for incorporation of more reliable quantitative measures for clinical decision making.
One- versus two-stage partial hepatectomy for large resectable solitary hepatocellular carcinomas determined preoperatively to have a narrow resection margin: a propensity score matching analysis
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:662-674
.
(10 October 2022)
For patients with a large but resectable solitary HCC of >5cm in diameter and a preoperative estimated resection margin, of <1.0cm, two-stage resection could extend resection margins and resulted in significantly better long-term survival outcomes after partial hepatectomy.
Automated liver tumor detection in abdominal ultrasonography with a modified faster region-based convolutional neural networks (Faster R-CNN) architecture
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:675-683
.
(10 October 2022)
We constructed the model based on Faster region-based Convolutional Neural Networks for the detection of tumor tissues and blood vessels from the sequential liver ultrasound images. The comparison between the proposed model and the based model shows that we achieved better accuracy in tumor detection.
The influence of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on the N- and M-staging and subsequent clinical management of intrahepatic cholangiocarcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:684-695
.
(10 October 2022)
PET/CT is superior to conventional imaging in diagnosing lymph node metastasis and distant metastasis, which improves the accuracy of tumor staging from 60.1% to 71.8%, and refines clinical management in 5.8% of ICC patients. PET/CT may bring survival benefits for ICC patients.
Review Article
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:696-708
.
(10 October 2022)
Using a novel method for network meta-analysis, the effectiveness of surgical and non-surgical therapies including the newly developed drugs was compared. Surgery is more effective to resolve NASH compared to drug treatment and while both are equally effective regarding improvement of fibrosis.
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:709-717
.
(10 October 2022)
HCC with Type II and Ⅲ PVTT are the most common in the included patients. 22.8% patients are evaluated as partial response after preoperative radiotherapy. Neoadjuvant radiotherapy followed by hepatectomy prolongs the survival for resectable HCC with PVTT.
French Commentary from the ACHBPT
Algorithm-based care for early recognition and management of complications after pancreatic resection: toward standardization of postoperative care
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:718-720
.
(10 October 2022)
Editorial
Ethical issues in innovative clinical research
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:721-723
.
(10 October 2022)
Hepatocellular carcinoma mutation landscape and its differences between Asians and Whites
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:724-728
.
(10 October 2022)
Liver cirrhosis and sarcopenia: a dreadful combination
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:729-731
.
(10 October 2022)
ALPPS and the endless pursuit of hepatic resectability
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:732-734
.
(10 October 2022)
The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:735-737
.
(10 October 2022)
Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:738-742
.
(10 October 2022)
Enlarged and uncommon indications for ALPPS—where do we stand?
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:743-745
.
(10 October 2022)
Is the exposure to liver transplantation worthwhile for trainees in liver surgery?
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:746-748
.
(10 October 2022)
Breast cancer liver metastasis: time to resection and criteria
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:749-751
.
(10 October 2022)
The microbiome as a potential diagnostic biomarker for pancreatic ductal adenocarcinoma (PDAC)
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:752-754
.
(10 October 2022)
Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:755-758
.
(10 October 2022)
Determinants of prognosis in cirrhosis: a new outlook
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:759-761
.
(10 October 2022)
Advancing proteomics and machine learning in the clinic: an editorial on “Noninvasive proteomic biomarkers for alcohol-related liver disease”
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:762-765
.
(10 October 2022)
Commentary
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:766-769
.
(10 October 2022)
Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:770-772
.
(10 October 2022)
Beyond management to conquer life-threatening tumor thrombosis in hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:773-774
.
(10 October 2022)
How we use hepatic arterial infusion chemotherapy in the new era of systemic therapy?
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:775-778
.
(10 October 2022)
Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:779-781
.
(10 October 2022)
Viewpoint
Hepatocellular carcinoma with portal invasion, still a place for liver surgery in the era of immunotherapy?
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:782-784
.
(10 October 2022)
Letter to the Editor
Emergent hybrid-dual-graft liver transplantation: a life-saving strategy for a patient with inadequate living donor graft during the COVID-19 pandemic
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:785-788
.
(10 October 2022)
18F-fluorodeoxyglucose positron emission tomography for intrahepatic cholangiocarcinoma N- and M-staging: should guidelines recommend it at last?
HepatoBiliary Surgery and Nutrition
2022;
11
(5)
:789-792
.
(10 October 2022)
